Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Background. Chemotherapy has become a standard of treatment in managing breast cancer. To achieve proper treatment for the right patients, the predictive marker is needed. Ki-67 is a biomarker of proliferation for solid tumor. Studies mentioned association of Ki-67 expression with chemotherapy respo...

Full description

Bibliographic Details
Main Authors:	Prihantono Prihantono, Mochammad Hatta, Christian Binekada, Daniel Sampepajung, Haryasena Haryasena, Berti Nelwan, Andi Asadul Islam, Andi Nilawati Usman
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	Journal of Oncology
Online Access:	http://dx.doi.org/10.1155/2017/6209849

Similar Items

The correlation between value of tumor markers CA 15-3 and CEA on histopathology grading, metastasis, disease free-survival and overall survival in women with breast cancer
by: Rudy Budijono, Haryasena Haryasena, Prihantono Prihantono, Muhammad Faruk
Published: (2020-12-01)

Seven Years Old Girl With Ductal Carcinoma In Situ – A Case Report
by: Prihantono Prihantono, Yendri Januardi, Salman Ardi Syamsu, Haryasena Haryasena
Published: (2019-08-01)

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
by: Fasching Peter A, et al.
Published: (2011-11-01)

Epidemiological and clinicopathological characteristics of breast cancer in Eastern Indonesia
by: Elanda Putri Madyaningtias, et al.
Published: (2021-01-01)

Association of Ki-67 Expression and Response of Neoadjuvant Chemotherapy in Invasive Breast Cancer Patients in Bandung
by: Andri Rezano, et al.
Published: (2018-09-01)

Predicting Response to Neoadjuvant Chemotherapy in Women with Locally Advanced Breast Cancer in Kenya: Utility of Ki67
by: Edwin Mogere, et al.
Published: (2021-01-01)

Can Ki-67 Play a Role in Prediction of Breast Cancer Patients' Response to Neoadjuvant Chemotherapy?
by: Juhasz-Böss Ingolf, et al.
Published: (2014-01-01)

Impact Of Tissue Sampling On Accuracy Of Ki67 Immunohistochemistry Evaluation In Breast Cancer
by: Justinas Besusparis, et al.
Published: (2016-06-01)

Diagnostic ability of real-time quantitative polymerase chain reaction versus immunohistochemistry for Ki-67 assessment in breast cancer: An Indian perspective
by: Anurag Mehta, et al.
Published: (2019-01-01)

Impact of neoadjuvant chemotherapy on Ki67 proliferation index and PDL1 expression in muscle-invasive bladder cancer
by: H. Horiguchi, et al.
Published: (2020-07-01)

Serum interleukin-17 (IL-17) level in breast carcinoma before and after chemotherapy
by: Ariyana, et al.
Published: (2020-06-01)

α-SMA and Ki-67 Immunohistochemistry as Indicators for the Fibrotic Remodeling Process in the Liver of Dogs
by: S. Neumann, et al.
Published: (2012-01-01)

ADJUVANTS THERAPY IN ORAL CANCER
by: Prihantono Prihantono
Published: (2018-10-01)

Prognostic value of the immunohistochemistry correlation of Ki-67 and p53 in squamous cell carcinomas of the larynx
by: Ricardo Boose Rodrigues, et al.
Published: (2008-11-01)

Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer.
by: Yuqin Ding, et al.
Published: (2020-01-01)

Decrease in the Ki67 index during neoadjuvant chemotherapy predicts favorable relapse-free survival in patients with locally advanced breast cancer
by: Chunfa Chen, et al.
Published: (2019-09-01)

Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience
by: Mirco Pistelli, et al.
Published: (2021-01-01)

Immunohistochemistry Analysis of P53 and Ki-67 Proteins in Oral Lichen Planus and Normal Oral Mucosa
by: F Agha-Hosseini, et al.
Published: (2009-06-01)

Immunohistochemistry Analysis of P53 and Ki-67 Proteins in Oral Lichen Planus and Normal Oral Mucosa
by: F Agha-Hosseini, et al.
Published: (2009-06-01)

Analysis of Routine Blood Profile as Data Supporting for Nursing Assessment in Breast Cancer Patients Undergoing Chemotherapy Treatment at the RSU. Dr. Wahidin Sudirohusodo
by: Yuliana Syam, et al.
Published: (2020-01-01)

The correlation of Foxp3 + gene and regulatory T cells with scar BCG formation among children with Tuberculosis
by: Farsida, et al.
Published: (2020-12-01)

Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy
by: Albert Font, et al.
Published: (2020-07-01)

A Novel Model Incorporating Tumor Stiffness, Blood Flow Characteristics, and Ki-67 Expression to Predict Responses After Neoadjuvant Chemotherapy in Breast Cancer
by: Jing Zhang, et al.
Published: (2020-12-01)

Expression of mRNA IL-17F and sIL-17F in atopic asthma patients
by: Mochammad Hatta, et al.
Published: (2017-06-01)

Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer
by: Garazi Serna, et al.
Published: (2020-10-01)

Risk Assessment in Hereditary Colorectal Cancer Family by Using APC and MSH2 mRNA Gene Expression and Bayesian Analysis
by: Tjahjadi Robert Tedjasaputra, et al.
Published: (2020-12-01)

Incidentally found intra-renal teratoma in adult: A case report and review of the literature
by: Muhammad Asykar Palinrungi, Prihantono Prihantono
Published: (2019-10-01)

Association of ki67 and tumor marker p53 in locally advanced breast cancer patients and evaluation of response to neoadjuvant chemotherapy: a survey in South Iran
by: Firouzabadi D, et al.
Published: (2019-07-01)

Ki67 Index Changes and Tumor-Infiltrating Lymphocyte Levels Impact the Prognosis of Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
by: Yihua Wang, et al.
Published: (2021-06-01)

Role of calcium-sensing receptor, Galectin-3, Cyclin D1, and Ki-67 immunohistochemistry to favor in the diagnosis of parathyroid carcinoma
by: Nuran Sungu, et al.
Published: (2018-01-01)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
by: Francesca Di Rosa, et al.
Published: (2021-04-01)

How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists.
by: Zsuzsanna Varga, et al.
Published: (2012-01-01)

An assessment of the diagnostic criteria for sessile serrated adenoma/polyps: SSA/Ps using image processing software analysis for Ki67 immunohistochemistry
by: Fujimori Yukari, et al.
Published: (2012-05-01)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
by: Francesca Di Rosa, et al.
Published: (2021-09-01)

Avoidance and Period-Shortening of Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer in Stages I and II: Importance of Ki-67 Labeling Index and the Recognition of Apocrine-Type Lesions
by: Koichi Kubouchi MD, et al.
Published: (2020-07-01)

High Ki-67 and Vascular Endothelial Growth Factor (VEGF) Protein Expression as Negative Predictive Factor for Combined Neoadjuvant Chemotherapy in Young Age Stage III Breast Cancer
by: I Wayan Sudarsa, et al.
Published: (2016-05-01)

The intrinsically disorderly story of Ki-67
by: Lucy Remnant, et al.
Published: (2021-08-01)

Expression of p16 and pKi-67 in cervical preneoplasia and neoplasia
by: Looi, Mee-Lee, et al.
Published: (2011)

Quantitative Immunohistochemistry for Evaluating the Distribution of Ki67 and Other Biomarkers in Tumor Sections and Use of the Method to Study Repopulation in Xenografts after Treatment with Paclitaxel
by: Andrea S. Fung, et al.
Published: (2012-04-01)

Possibility of using НЕR-2/NEU & KI-67, as prognostic factors of distal stomach tumor answer for neoadjuvant therapy
by: Dumanskij Yu.V., et al.
Published: (2008-01-01)